Literature DB >> 15458853

Derivation of a definition of remission on the Montgomery-Asberg depression rating scale corresponding to the definition of remission on the Hamilton rating scale for depression.

Mark Zimmerman1, Michael A Posternak, Iwona Chelminski.   

Abstract

During the past decade the Montgomery-Asberg Depression Rating Scale (MADRS) has been used with increasing frequency to measure outcome in antidepressant efficacy trials (AETs). In characterizing treatment outcome in AETs it is common to define treatment remission as a score below a predetermined cutoff score on the scale. Various cutoffs have been used to define remission on the MADRS. The goal of the present paper is to determine the cutoff on the MADRS that most closely corresponds to the cutoff most frequently used on the Hamilton Rating Scale for Depression to define remission. Three hundred and three psychiatric outpatients who were being treated for a DSM-IV major depressive episode were rated on the HRSD and the MADRS. A linear regression equation was computed to estimate MADRS scores from HRSD scores. After deriving the regression equation, we computed the MADRS score corresponding to an HRSD score of 7. We also examined the sensitivity, specificity and overall classification rate of the MADRS for identifying remission on the HRSD. Based on the equation from a linear regression analysis for the entire sample, a MADRS score of </=11 would correspond to a score of </=7 on the HRSD. We repeated the analysis after excluding the more severely depressed patients who currently met criteria for MDD, and based on the equation from this regression analysis a MADRS score of </=10 would correspond to a score of </=7 on the HRSD. In a complementary analysis, we examined the sensitivity, specificity and overall classification rate of the MADRS at different cutoff points for identifying remission, and found that a cutoff of </=10 maximized the level of agreement with the HRSD definition of remission. In conclusion, the regression equation relating HRSD and MADRS scores is dependent, in part, on the range and severity of scores in the sample. To facilitate comparisons of studies using the HRSD and MADRS our results suggest that a cutoff of 10 on the MADRS is equivalent to the HRSD cutoff of 7.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15458853     DOI: 10.1016/j.jpsychires.2004.03.007

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  46 in total

1.  Feasibility study of an interactive multimedia electronic problem solving treatment program for depression: a preliminary uncontrolled trial.

Authors:  Margit I Berman; Jay C Buckey; Jay G Hull; Eftihia Linardatos; Sueyoung L Song; Robert K McLellan; Mark T Hegel
Journal:  Behav Ther       Date:  2014-02-07

2.  Paroxetine versus other anti-depressive agents for depression.

Authors:  Andrea Cipriani; Toshi A Furukawa; Antonio Veronese; Norio Watanabe; Rachel Churchill; Hugh McGuire; Corrado Barbui
Journal:  Cochrane Database Syst Rev       Date:  2007

3.  Venlafaxine versus other anti-depressive agents for depression.

Authors:  Andrea Cipriani; Alessandra Signoretti; Toshi A Furukawa; Rachel Churchill; Silva Tomelleri; Ichiro M Omori; Hugh McGuire; Corrado Barbui
Journal:  Cochrane Database Syst Rev       Date:  2007

4.  Sexual Pain among Malaysian Women Receiving Antidepressant: A Comparison between Escitalopram and Fluoxetine.

Authors:  Hatta Sidi; Duni Asmidar; Loh Huai Seng; Nik Ruzyanei Nik Jaafar; Marhani Midi; Ng Chong Guan
Journal:  Psychopharmacol Bull       Date:  2016-03-01

5.  Accurately predicting bipolar disorder mood outcomes: implications for the use of electronic databases.

Authors:  Alisa B Busch; Brian Neelon; Katya Zelevinsky; Yulei He; Sharon-Lise T Normand
Journal:  Med Care       Date:  2012-04       Impact factor: 2.983

6.  Screening for depressive symptoms in patients with unresectable lung cancer.

Authors:  S Néron; J A Correa; E Dajczman; G Kasymjanova; H Kreisman; D Small
Journal:  Support Care Cancer       Date:  2007-02-14       Impact factor: 3.603

7.  Depression relapse prophylaxis with Mindfulness-Based Cognitive Therapy: replication and extension in the Swiss health care system.

Authors:  Guido Bondolfi; Françoise Jermann; Martial Van der Linden; Marianne Gex-Fabry; Lucio Bizzini; Béatrice Weber Rouget; Lusmila Myers-Arrazola; Christiane Gonzalez; Zindel Segal; Jean-Michel Aubry; Gilles Bertschy
Journal:  J Affect Disord       Date:  2009-08-08       Impact factor: 4.839

8.  Depression in lung cancer patients: is the HADS an effective screening tool?

Authors:  Lorys Castelli; Luca Binaschi; Paola Caldera; Riccardo Torta
Journal:  Support Care Cancer       Date:  2009-03-13       Impact factor: 3.603

9.  Identification of Distinct Latent Classes Related to Sleep, PTSD, Depression, and Anxiety in Individuals Diagnosed With Severe Alcohol Use Disorder.

Authors:  Gwenyth R Wallen; Jumin Park; Michael Krumlauf; Alyssa T Brooks
Journal:  Behav Sleep Med       Date:  2018-01-29       Impact factor: 2.964

10.  The Bipolar Interactive Psychoeducation (BIPED) study: trial design and protocol.

Authors:  Sharon Simpson; Emma Barnes; Emily Griffiths; Kerry Hood; David Cohen; Nick Craddock; Ian Jones; Daniel J Smith
Journal:  BMC Psychiatry       Date:  2009-08-12       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.